This page shows the latest psychiatric diseases news and features for those working in and with pharma, biotech and healthcare.
Jay Bradner, president of the Novartis Institutes for Biomedical Research, said: "Psychiatric and neurodegenerative diseases place a heavy physical, mental and economic burden on patients and their families. ... With widespread adoption of digital devices
The team of neuroscientists was identified by Boehringer and BioMed X via a crowdsourcing competition tasked with exploring the 'most promising solution approaches' to psychiatric diseases. ... Last year, Boehringer Ingelheim entered into a psychiatric
All four collaborations are focusing on research into inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, looking at new therapeutic targets as well as biomarkers that can be ... In addition, the company signed a deal with Circuit
As president of Dey Pharma, Thievon will drive the company's focus on medicines to treat respiratory diseases, severe allergic reactions and psychiatric disorders.
Neurocrine and GSK signed a worldwide research, development and commercialisation agreement for Corticotropin Releasing Factor Receptor Antagonists for psychiatric, neurological and gastrointestinal diseases in 2001.
Ireland's first Genome Sequencing Laboratory will enable research into psychiatric disorders, infectious diseases, disorders of the immune system and other human diseases.
More from news
Approximately 1 fully matching, plus 6 partially matching documents found.
Product portfolio covering rare diseases in haematology, immunology, oncology; cash and stock deal at 37.5% share price premium. ... diseases and other indications targeting an undisclosed orphan G protein–coupled receptor (GPCR) . 262. Dual
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Before joining Stanford, he spent 25 years at the University of Texas as chairman of the department of neuroscience researching neuro-degenerative and neuro-psychiatric diseases.
Goupit said: “I strongly believe that MedDay's product pipeline and its research platform, SPECMET, could have a major impact on the treatment of neurological and psychiatric diseases.”.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
This means that while successful drugs for psychiatric diseases have been introduced into the market, subsequent new drugs are based on similar mechanisms of actions or therapeutic targets. ... The answer is simple, while bacterial and viral infections
With over 9 years’ experience in medical communications, Aki Okazaki who is joining as an Associate Director, has worked in a broad range of therapeutic areas including haematology, infectious diseases, oncology, ... psychiatric conditions, rare
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...